184 related articles for article (PubMed ID: 29021610)
1. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells.
Itakura G; Ozaki M; Nagoshi N; Kawabata S; Nishiyama Y; Sugai K; Iida T; Kashiwagi R; Ookubo T; Yastake K; Matsubayashi K; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
Sci Rep; 2017 Oct; 7(1):12996. PubMed ID: 29021610
[TBL] [Abstract][Full Text] [Related]
2. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic activities of engrafted neural stem/precursor cells are not dormant in the chronically injured spinal cord.
Kumamaru H; Saiwai H; Kubota K; Kobayakawa K; Yokota K; Ohkawa Y; Shiba K; Iwamoto Y; Okada S
Stem Cells; 2013 Aug; 31(8):1535-47. PubMed ID: 23606608
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
[TBL] [Abstract][Full Text] [Related]
6. Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury.
Oh J; Lee KI; Kim HT; You Y; Yoon DH; Song KY; Cheong E; Ha Y; Hwang DY
Stem Cell Res Ther; 2015 Jun; 6(1):125. PubMed ID: 26104416
[TBL] [Abstract][Full Text] [Related]
7. Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells.
Kajikawa K; Imaizumi K; Shinozaki M; Shibata S; Shindo T; Kitagawa T; Shibata R; Kamata Y; Kojima K; Nagoshi N; Matsumoto M; Nakamura M; Okano H
Mol Brain; 2020 Sep; 13(1):120. PubMed ID: 32883317
[TBL] [Abstract][Full Text] [Related]
8. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
[TBL] [Abstract][Full Text] [Related]
9. Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.
Strnadel J; Carromeu C; Bardy C; Navarro M; Platoshyn O; Glud AN; Marsala S; Kafka J; Miyanohara A; Kato T; Tadokoro T; Hefferan MP; Kamizato K; Yoshizumi T; Juhas S; Juhasova J; Ho CS; Kheradmand T; Chen P; Bohaciakova D; Hruska-Plochan M; Todd AJ; Driscoll SP; Glenn TD; Pfaff SL; Klima J; Ciacci J; Curtis E; Gage FH; Bui J; Yamada K; Muotri AR; Marsala M
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743351
[TBL] [Abstract][Full Text] [Related]
10. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
[TBL] [Abstract][Full Text] [Related]
11. Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury.
Watanabe K; Nakamura M; Iwanami A; Fujita Y; Kanemura Y; Toyama Y; Okano H
Dev Neurosci; 2004; 26(2-4):275-87. PubMed ID: 15711067
[TBL] [Abstract][Full Text] [Related]
12. CHD7 promotes proliferation of neural stem cells mediated by MIF.
Ohta S; Yaguchi T; Okuno H; Chneiweiss H; Kawakami Y; Okano H
Mol Brain; 2016 Dec; 9(1):96. PubMed ID: 27955690
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair.
Romanyuk N; Amemori T; Turnovcova K; Prochazka P; Onteniente B; Sykova E; Jendelova P
Cell Transplant; 2015; 24(9):1781-97. PubMed ID: 25259685
[TBL] [Abstract][Full Text] [Related]
14. Origin-dependent neural cell identities in differentiated human iPSCs in vitro and after transplantation into the mouse brain.
Hargus G; Ehrlich M; Araúzo-Bravo MJ; Hemmer K; Hallmann AL; Reinhardt P; Kim KP; Adachi K; Santourlidis S; Ghanjati F; Fauser M; Ossig C; Storch A; Kim JB; Schwamborn JC; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H
Cell Rep; 2014 Sep; 8(6):1697-1703. PubMed ID: 25220454
[TBL] [Abstract][Full Text] [Related]
15. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
[TBL] [Abstract][Full Text] [Related]
16. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
[TBL] [Abstract][Full Text] [Related]
17. Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro.
Liu J; Götherström C; Forsberg M; Samuelsson EB; Wu J; Calzarossa C; Hovatta O; Sundström E; Åkesson E
Stem Cell Res; 2013 May; 10(3):325-37. PubMed ID: 23416350
[TBL] [Abstract][Full Text] [Related]
18. Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells.
Kumamaru H; Ohkawa Y; Saiwai H; Yamada H; Kubota K; Kobayakawa K; Akashi K; Okano H; Iwamoto Y; Okada S
Nat Commun; 2012; 3():1140. PubMed ID: 23072808
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury.
Okada S; Ishii K; Yamane J; Iwanami A; Ikegami T; Katoh H; Iwamoto Y; Nakamura M; Miyoshi H; Okano HJ; Contag CH; Toyama Y; Okano H
FASEB J; 2005 Nov; 19(13):1839-41. PubMed ID: 16141363
[TBL] [Abstract][Full Text] [Related]
20. Applications of induced pluripotent stem cell technologies in spinal cord injury.
Nagoshi N; Okano H
J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
